{"podcast":{"title":"The BioHub - by Avetix","slug":"the-biohub-by-avetix-7252289","podcast_index_feed_id":7252289,"rss_url":"https://anchor.fm/s/f0076084/podcast/rss","website_url":"https://podcasters.spotify.com/pod/show/max-brennan4","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40170153/40170153-1775724702970-e7a36a5e3cf58.jpg","author":"Max Brennan - Biotech HeadHunter","episode_count":230,"summary":"Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that's shaping the future of biotechnology. Get ready for an immersive experience into the world of biotech with The BioHub.","last_synced_at":"2026-07-21T04:19:24.893516+00:00","page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289"},"episode":{"title":"Episode 180 - Ben Zimmer - CEO of Priovant Therapeutics","slug":"episode-180-ben-zimmer-ceo-of-priovant-therapeutics","published_at":"2026-05-26T14:41:42+00:00","page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-180-ben-zimmer-ceo-of-priovant-therapeutics","show_page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289","url":"https://podcasters.spotify.com/pod/show/max-brennan4/episodes/Episode-180---Ben-Zimmer---CEO-of-Priovant-Therapeutics-e3jn2bm","audio_url":"https://anchor.fm/s/f0076084/podcast/play/120342326/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-26%2F424914274-44100-2-5c7d691a53bfc.mp3","summary":"In this episode of The BioHub Podcast , Max sits down with Ben Zimmer, CEO of Priovant Therapeutics. Ben was among the first ten employees at Roivant, helping incubate and launch multiple biotech companies before going on to found Priovant in 2021. Priovant is a clinical-stage biotech focused on developing therapies for severe autoimmune diseases — one of the most active and fast-moving areas in biotech today. In this conversation, we talk about the early days of Roivant, the inspiration behind building Priovant, why autoimmune disease has become such a major focus across the industry, and what it takes to build teams and companies in high-stakes therapeutic areas. We also discuss leadership, decision-making, and what’s next for Priovant.","meta_description":"In this episode of The BioHub Podcast , Max sits down with Ben Zimmer, CEO of Priovant Therapeutics. Ben was among the first ten employees at Roivant, hel…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1676,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-180-ben-zimmer-ceo-of-priovant-therapeutics/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-180-ben-zimmer-ceo-of-priovant-therapeutics.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}